DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/xp57mb/global_bladder) has announced the addition of the "Global Bladder Cancer Drug Pipeline Capsule - 2012 Update" report to their offering.
Fore Pharma's latest report 'Global Bladder Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Bladder Cancer market. It covers active Bladder Cancer pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Bladder Cancer - Disease Overview
2. Bladder Cancer Pipeline Overview
3. Bladder Cancer Phase 3 Clinical Trial Pipeline Insights
4. Bladder Cancer Phase 2 Clinical Trial Pipeline Insights
5. Bladder Cancer Phase 1 Clinical Trial Pipeline Insights
6. Bladder Cancer Preclinical Research Pipeline Insights
7. Bladder Cancer Discovery Stage Pipeline Insights
8. Bladder Cancer Drug Development Activities - Geographic Landscape
8.1. Bladder Cancer R&D Activities in North America
8.2. Bladder Cancer R&D Activities in Europe
9. Bladder Cancer Pipeline - Licensing Activities
Table 1. Bladder Cancer Pipeline Molecules - Phase 3 Clinical Trial
Table 2. Bladder Cancer Pipeline Molecules - Phase 2 Clinical Trial
Table 3. Bladder Cancer Pipeline Molecules - Phase 1 Clinical Trial
Table 4. Bladder Cancer Pipeline Molecules - Preclinical Research
Table 5. Bladder Cancer Pipeline Molecules - Drug Discovery
Table 6. Bladder Cancer R&D Activities by Geography
Table 7. Bladder Cancer Pipeline Molecules - North America
Table 8. Bladder Cancer Pipeline Molecules - Europe
Table 9. Bladder Cancer Pipeline - Licensing Activities
Figure 1. Bladder Cancer Pipeline Molecules by R&D Stage
Figure 2. Bladder Cancer R&D Activities by Geography
For more information visit http://www.researchandmarkets.com/research/xp57mb/global_bladder